MedPath

LOWOX

Not yet recruiting
Conditions
Surgery under general anesthesia
Registration Number
2024-513117-12-00
Lead Sponsor
Region Vaesterbotten, Umea University
Brief Summary

To investigate if there is an improvement in postoperative arterial oxygen partial pressure (PaO2) after goal-directed low oxygen concentration during anesthesia compared to the routine use with fixed oxygen concentrations.

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised, recruitment pending
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Adults (> 18 years old)

The subject has given their written consent to participate in the trial.

Be scheduled for abdominal surgery performed at the Departments of Surgery, Urology and Gynecology lasting more than 2 hours.

Fall under the American Society of Anesthesia (ASA) Class 1-3.

Exclusion Criteria

Increased risk for difficult intubation during anesthesia (Mallampati score 3-4) or previous documentation of difficult intubation.

The inability to understand written or verbal information, thereby hindering the ability to provide informed consent.

Obese with a BMI >35 kg/m2.

Participation or recent participation within 30 days in a clinical trial with an investigational medicinal product. Previous participation in this trial.

Pregnancy

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Arterial oxygen partial pressure (PaO2) measured on postoperative day 2 compared to the day before surgery. Supplemental oxygen will be ceased before the blood sampling, if possible, for 30 minutes or longer.

Arterial oxygen partial pressure (PaO2) measured on postoperative day 2 compared to the day before surgery. Supplemental oxygen will be ceased before the blood sampling, if possible, for 30 minutes or longer.

Secondary Outcome Measures
NameTimeMethod
Change in diffusion capacity for carbon monoxide on day 2 and after 3 months compared to the day preceding surgery (=baseline).

Change in diffusion capacity for carbon monoxide on day 2 and after 3 months compared to the day preceding surgery (=baseline).

Change in vital capacity (VC) on day 2 and after 3 months compared to baseline.

Change in vital capacity (VC) on day 2 and after 3 months compared to baseline.

Change in PaO2 and PaCO2 on day 1 and after 3 months compared to baseline.

Change in PaO2 and PaCO2 on day 1 and after 3 months compared to baseline.

Surgical site infections within 30 days of surgery.

Surgical site infections within 30 days of surgery.

Postoperative recovery using the Postoperative Recovery Profile at discharge and after 3 months

Postoperative recovery using the Postoperative Recovery Profile at discharge and after 3 months

Hospital length of stay.

Hospital length of stay.

Effect of background variables on outcomes, including age, sex, height, weight, body mass index (BMI), type of surgery, duration of surgery, and type of anesthesia.

Effect of background variables on outcomes, including age, sex, height, weight, body mass index (BMI), type of surgery, duration of surgery, and type of anesthesia.

Trial Locations

Locations (3)

Region Norrbotten

🇸🇪

Lulea, Sweden

Region Vaesterbotten

🇸🇪

Umea, Sweden

Region Vaesternorrland

🇸🇪

Sundsvall, Sweden

Region Norrbotten
🇸🇪Lulea, Sweden
Tomi Myrberg
Site contact
0920284000
tomi.myrberg@umu.se

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.